• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 20, 1998

View Archived Issues

Synvisc approved for treatment of osteoarthritis in Argentina and Brazil

Read More

New imaging agents in the pipeline at Mallinckrodt

Read More

Testoderm introduced in two more important markets: China and Germany

Read More

Ribi, ATL collaborate on the development of improved allergy vaccines

Read More

Celsion ready to begin BPH treatment studies

Read More

Novel radiopharmaceutical agent available for licensing from BTG

Read More

Clinical trial results reported, development plans outlined for Aastrom stem cell therapy system

Read More

Novel CNS technology with broad potential application available from BTG

Read More

FDA awards fast track status and development grant to Surfaxin

Read More

NitroMed presents preclinical data on NO-enhanced compounds to treat male erectile dysfuntion

Read More

Statins provide protection against stroke via effects on eNOS

Read More

Good efficacy, tolerability reported for Almirall Prodesfarma's antimigraine candidate

Read More

Paclitaxel derivatives useful as antitumor agents prepared at BMS

Read More

Neurotrophic/neuroprotective agents in development at Sanofi

Read More

Isoflavone derivatives for osteoporosis with advantages over previously reported compounds

Read More

New AMPA and NMDA receptor antagonists in early research at RPR

Read More

Dopamine reuptake inhibitors in development at Pola for Parkinson's disease

Read More

First clinical findings presented for Lilly/Synaptic antimigraine drug

Read More

Taisho describes antiischemic 2-phenoxyaniline derivatives

Read More

Gene-based CF therapeutic developed by Megabios and Glaxo Wellcome proves safe in humans

Read More

Phase II trial of tgAAV-CF completed, preliminary data presented at CF conference

Read More

Positive phase I safety and efficacy results reported for INS-365

Read More

BMS acquires new antibacterial compound from Toyama

Read More

Phase I study results reported for rNAPc2; further testing of novel anticoagulant recommended

Read More

FDA Cardiovascular and Renal Drugs Advisory Committee meets this week

Read More

Yamanouchi introduces novel formulation of antiemetic drug

Read More

Ziagen to be reviewed by FDA advisory committee in early November

Read More

Glaxo Wellcome files application for new HIV protease inhibitor in Canada

Read More

ODAC votes against Warner-Lambert's prostate cancer drug

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe